Insider Selling: CryoPort, Inc. (NASDAQ:CYRX) CEO Sells 69,135 Shares of Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 69,135 shares of the stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $6.47, for a total transaction of $447,303.45. Following the completion of the sale, the chief executive officer now owns 912,419 shares of the company's stock, valued at $5,903,350.93. This trade represents a 7.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Jerrell Shelton also recently made the following trade(s):

• On Tuesday, June 17th, Jerrell Shelton sold 151,304 shares of CryoPort stock. The stock was sold at an average price of $6.81, for a total transaction of $1,030,380.24.
• On Wednesday, June 18th, Jerrell Shelton sold 119,281 shares of CryoPort stock. The shares were sold at an average price of $6.81, for a total transaction of $812,303.61.
• On Monday, March 24th, Jerrell Shelton sold 2,980 shares of CryoPort stock. The stock was sold at an average price of $6.94, for a total value of $20,681.20.

CryoPort Trading Down 6.0%

CYRX traded down $0.41 on Friday, hitting $6.37. The company had a trading volume of 607,870 shares, compared to its average volume of 532,638. The company's fifty day moving average price is $6.19 and its 200 day moving average price is $6.72. CryoPort, Inc. has a 1 year low of $4.58 and a 1 year high of $9.93. The company has a current ratio of 5.56, a quick ratio of 5.24 and a debt-to-equity ratio of 0.51. The firm has a market cap of $319.39 million, a P/E ratio of -2.72 and a beta of 1.85.

CryoPort (NASDAQ:CYRX - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $41.04 million during the quarter, compared to analysts' expectations of $56.19 million. CryoPort had a negative net margin of 50.15% and a negative return on equity of 11.03%. As a group, equities analysts expect that CryoPort, Inc. will post -0.99 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Morgan Stanley lowered their price objective on CryoPort from $8.00 to $7.00 and set an "equal weight" rating on the stock in a research note on Monday, May 5th. Guggenheim reiterated a "buy" rating and set a $10.00 price target on shares of CryoPort in a report on Wednesday, April 16th. UBS Group boosted their price target on shares of CryoPort from $10.00 to $11.00 and gave the company a "buy" rating in a research report on Tuesday, April 1st. Roth Mkm restated a "buy" rating and set a $15.00 price objective on shares of CryoPort in a research report on Tuesday, April 1st. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $11.00 target price on shares of CryoPort in a report on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, CryoPort presently has an average rating of "Moderate Buy" and a consensus target price of $11.00.

Institutional Trading of CryoPort

Several institutional investors have recently added to or reduced their stakes in CYRX. Point72 Asia Singapore Pte. Ltd. grew its stake in shares of CryoPort by 148.7% in the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,546 shares of the company's stock valued at $28,000 after buying an additional 2,120 shares in the last quarter. Lazard Asset Management LLC acquired a new position in CryoPort in the 4th quarter valued at about $51,000. Quarry LP acquired a new position in CryoPort in the 4th quarter valued at about $69,000. SBI Securities Co. Ltd. increased its stake in CryoPort by 548,750.0% during the first quarter. SBI Securities Co. Ltd. now owns 10,977 shares of the company's stock worth $67,000 after purchasing an additional 10,975 shares during the period. Finally, CWM LLC lifted its position in shares of CryoPort by 1,437.0% during the first quarter. CWM LLC now owns 11,328 shares of the company's stock worth $69,000 after purchasing an additional 10,591 shares in the last quarter. Institutional investors and hedge funds own 92.90% of the company's stock.

About CryoPort

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.